The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
Top Cited Papers
Open Access
- 1 February 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (2), 421-432
- https://doi.org/10.1002/art.21625
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Criteria for steroid‐sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meetingArthritis & Rheumatism, 2004
- Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamideKidney International, 2000
- Lupus nephritisKidney International, 1997
- Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic dataKidney International, 1994
- Measurement of renal function in chronic renal diseaseKidney International, 1990
- Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patientsArthritis & Rheumatism, 1990
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986
- Effect of Treatment on the Evolution of Renal Abnormalities in Lupus NephritisThe New England Journal of Medicine, 1984
- Pulse methylprednisolone therapy in diffuse proliferative lupus nephritisThe Journal of Pediatrics, 1982
- Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and CyclophosphamideThe New England Journal of Medicine, 1978